The prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer : a multi-center study with a propensity score-adjusted analysis
(2023) In Japanese journal of clinical oncology 53(8). p.698-703- Abstract
Objective: Complete-staging surgery is recommended for stage IA ovarian cancer, but may be omitted for various reasons, including the preservation of fertility and an advanced age. We herein investigated the prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer. Methods: We retrospectively collected data on 4730 patients with malignant ovarian tumors from the databases of multiple institutions and ultimately included 293 with stage IA epithelial ovarian cancer. Limited-staging surgery was defined as one that did not involve hysterectomy, systematic retroperitoneal lymphadenectomy or the collection of ascites cytology. We used an inverse probability of treatment weighting analysis with... (More)
Objective: Complete-staging surgery is recommended for stage IA ovarian cancer, but may be omitted for various reasons, including the preservation of fertility and an advanced age. We herein investigated the prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer. Methods: We retrospectively collected data on 4730 patients with malignant ovarian tumors from the databases of multiple institutions and ultimately included 293 with stage IA epithelial ovarian cancer. Limited-staging surgery was defined as one that did not involve hysterectomy, systematic retroperitoneal lymphadenectomy or the collection of ascites cytology. We used an inverse probability of treatment weighting analysis with propensity scores and estimated the hazard ratios of recurrence and death with limited-staging surgery. Results: In total, 176 out of 293 patients (39.9%) were assigned to the limited-staging surgery group. After propensity score adjustments, no significant differences were observed in recurrence-free survival or overall survival between the limited- and complete-staging surgery groups. Even in the subgroup analysis with age stratification, recurrence-free survival and overall survival were similar in the limited- and complete-staging surgery groups. Conclusions: The present results indicate the limited prognostic impact of limited-staging surgery for stage IA epithelial ovarian cancer.
(Less)
- author
- organization
- publishing date
- 2023-08
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- ascites cytology, fertility-sparing surgery, lymphadenectomy, ovarian cancer
- in
- Japanese journal of clinical oncology
- volume
- 53
- issue
- 8
- pages
- 6 pages
- publisher
- Oxford University Press
- external identifiers
-
- pmid:37236812
- scopus:85166387009
- ISSN
- 0368-2811
- DOI
- 10.1093/jjco/hyad039
- language
- English
- LU publication?
- yes
- id
- 052b2823-eaf0-470f-9d87-dd47228322fb
- date added to LUP
- 2023-11-02 12:16:30
- date last changed
- 2024-04-19 03:27:43
@article{052b2823-eaf0-470f-9d87-dd47228322fb, abstract = {{<p>Objective: Complete-staging surgery is recommended for stage IA ovarian cancer, but may be omitted for various reasons, including the preservation of fertility and an advanced age. We herein investigated the prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer. Methods: We retrospectively collected data on 4730 patients with malignant ovarian tumors from the databases of multiple institutions and ultimately included 293 with stage IA epithelial ovarian cancer. Limited-staging surgery was defined as one that did not involve hysterectomy, systematic retroperitoneal lymphadenectomy or the collection of ascites cytology. We used an inverse probability of treatment weighting analysis with propensity scores and estimated the hazard ratios of recurrence and death with limited-staging surgery. Results: In total, 176 out of 293 patients (39.9%) were assigned to the limited-staging surgery group. After propensity score adjustments, no significant differences were observed in recurrence-free survival or overall survival between the limited- and complete-staging surgery groups. Even in the subgroup analysis with age stratification, recurrence-free survival and overall survival were similar in the limited- and complete-staging surgery groups. Conclusions: The present results indicate the limited prognostic impact of limited-staging surgery for stage IA epithelial ovarian cancer.</p>}}, author = {{Miyamoto, Emiri and Suzuki, Hironori and Yoshihara, Masato and Mogi, Kazumasa and Iyoshi, Shohei and Uno, Kaname and Fujimoto, Hiroki and Kitami, Kazuhisa and Tano, Sho and Emoto, Ryo and Matsui, Shigeyuki and Kajiyama, Hiroaki}}, issn = {{0368-2811}}, keywords = {{ascites cytology; fertility-sparing surgery; lymphadenectomy; ovarian cancer}}, language = {{eng}}, number = {{8}}, pages = {{698--703}}, publisher = {{Oxford University Press}}, series = {{Japanese journal of clinical oncology}}, title = {{The prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer : a multi-center study with a propensity score-adjusted analysis}}, url = {{http://dx.doi.org/10.1093/jjco/hyad039}}, doi = {{10.1093/jjco/hyad039}}, volume = {{53}}, year = {{2023}}, }